BioScience Ventures Group
5
1M
5
1
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Munich. The company was established in Europe in Germany.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2007.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the BioScience Ventures Group, startups are often financed by Limburg Ventures. The meaningful sponsors for the fund in investment in the same round are NV Industriebank LIOF, Limburg Ventures, High-Tech Gru00fcnderfonds. In the next rounds fund is usually obtained by The Austrian Research Promotion Agency (FFG).
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Austria. Among the most successful fund investment fields, there are Biotechnology, Biopharma. Among the most popular portfolio startups of the fund, we may highlight APEPTICO Forschung und Entwicklung, ugichem.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 1
- Investments by industry
- Biotechnology (4)
- Medical (2)
- Therapeutics (2)
- Project Management (1)
- Nanotechnology (1) Show 3 more
- Investments by region
-
- Austria (2)
- Germany (2)
- Netherlands (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Diaferon | 09 Jul 2007 | Biotechnology | Seed | 927K | Munich, Bavaria, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.